Clinical Trial Results Archive

Clinical Trial Results: March 2008

March 3	Pro-Pharmaceuticals Davanat Extends Median Survival 6.7 Months for End-Stage Colorectal Cancer Patients After All Other Treatments Failed
March 3	Renovo Announces Results of Latest Phase 2 Studies of Juvista (Human Recombinant TGFbeta3)
March 3	Publication in Clinical Cancer Research Confirms Ability of Peregrine's Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
March 3	GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
March 3	Alexza's AZ-104 (Staccato Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
March 3	HUYA Bioscience Int'l Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
March 3	LifeCycle Pharma Announces Positive Top-line Results of Phase II Clinical Trial of LCP-Tacro for the Prevention of Organ Rejection after Kidney Transplantation
March 3	Array BioPharma Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical Trial
March 3	PhytoMedical's Latest Anti-Cancer Compounds Kill Human Colon Cancer Cells
March 3	Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
March 4	Inovio Biomedical to Present New Data from Melanoma Immunotherapy Clinical Trial at DNA Vaccines Forum 2008
March 4	Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Women's Cancer
March 4	Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss During Optic Neuritis in a Preclinical Model of Multiple Sclerosis
March 4	Advaxis Scientists Publish Research of Listeria Monocytogenes-Based Vaccine for Prostate Cancer in Latest Edition of Cancer Immunology & Immunotherapy
March 4	Lifetime Probability of Needing a Stem Cell Transplant is Much Higher Than Previously Reported, Data Shows
March 4	International symposium reports on the use of antivirals in patients with H5N1
March 4	Panacos Announces Discovery of Bevirimat Patient Response Predictors
March 4	UCB: Early Data on Cimzia from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
March 5	CHOP-Zevalin Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
March 5	Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
March 5	Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
March 6	PharmAthene Completes Pharmacokinetic Studies of Protexia; Program on Target for IND Filing in 2008
March 6	Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities
March 6	High Levels of Estrogen Associated with Breast Cancer Recurrence
March 6	ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
March 7	Alcon Presents Clinical Trial Data on Anecortave Acetate for Glaucoma
March 7	Juvista Phase II Trial Results in Scar Revision and Breast Augmentation Surgery
March 7	Repros' Proellex Safety Data Presented At The 13th World Congress of Gynecological Endocrinology
March 7	THE LANCET Publishes Phase IIa Study Results with Cytos Biotechnology’s Hypertension Vaccine CYT006-AngQb
March 7	SPMSD release: Gardasil
March 7	Experts Available to Discuss Study Showing Link Between High Levels of Estrogen and Breast Cancer Recurrence
March 10	Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
March 10	Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
March 10	Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
March 10	Sirtris Pharmaceuticals Collaborator Presents Neuroprotective Data for Oral Drug Candidate SRT501 at North American Neuro-Ophthalmology Society Meeting
March 10	Genzyme Announces Presentation of New Positive Data on Carticel
March 10	GSK Cervical Cancer Candidate Vaccine Cervarix Demonstrates Long-Term Protection for More Than Six Years
March 10	Anavex 7-1037 Reduces Rate of Cancer Tumor Growth 69% in Preclinical Studies, Compared to Currently Marketed Drug Dacarbazine Showing no Measurable Activity
March 10	Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology
March 10	Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
March 10	Clinical Data on Lenocta, a Protein Tyrosine Phosphatase Inhibitor in Development at VioQuest Pharmaceuticals, Accepted for Oral Presentation at ASCO
March 10	Potential Brain Cancer Drug for Children May Damage Bones
March 10	Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
March 11	I-Flow Leads Infection Prevention Trend by Using Silver with Antimicrobial Properties in Medical Devices
March 11	Genitope Corporation to Suspend Development of MyVax Personalized Immunotherapy
March 11	Femara helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
March 11	Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
March 11	Inovio Biomedical's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy
March 11	Peregrine Pharmaceuticals Announces Positive Data From Cotara Brain Cancer Trials
March 11	Oculus Innovative Sciences to Announce Additional Phase II Data and Data from Two Recent International Studies at DFCon 08
March 11	Nymox Releases Further Results from Latest U.S. Study of NX-1207 for Benign Prostatic Hyperplasia
March 11	Oxogeme Reports Positive Primate Ocular Tolerance and Penetration Data with Topical Formulation of Zybrestat for Ophthalmology
March 11	Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO
March 11	Nymox Releases Further Results from Latest U.S. Study of NX-1207 for Benign Prostatic Hyperplasia
March 12	Wyeth and Progenics Provide Update on Phase 3 Clinical Trial of Intravenous Methylnaltrexone for Postoperative Ileus
March 12	Avexa Reports Superior Results in ATC Phase IIb Clinical Trial Update
March 12	Urigen Announces Positive Phase II Clinical Trial Results with URG101
March 12	XenoPort Announces Positive Results of a Phase 1 Clinical Trial of XP21279
March 12	Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin
March 12	JAMA Article Provides False Support for CDC's Do-Nothing Position on MRSA
March 12	CombinatoRx Drug Candidate CRx-191 Demonstrates Positive Phase 2 Results in Psoriasis
March 12	OctoPlus Announces Publication of Phase I Locteron Results in the Journal of Interferon and Cytokine Research
March 13	Publication of Clinical Results Underscores Velcade (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
March 13	Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera for Gaucher Disease
March 13	Cambria Biosciences' Chemical Genetics Platform is Featured in Nature Article Describing a New Pharmaceutical Mode of Action
March 13	MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
March 13	Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis
March 13	Researchers Find Cause of Severe Allergic Reaction to Cancer Drug
March 13	Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
March 13	Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting
March 14	Inspire Announces Poster Presentations at 2008 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
March 14	Oculus Innovative Sciences Announces Additional Phase II Data for Microcyn Technology in Mildly Infected Diabetic Foot Ulcers
March 14	The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
March 14	Greer Reports Favorable Results of Phase IIb Clinical Trial of Short Ragweed Sublingual-Oral Immunotherapy at American Academy of Allergy Asthma and Immunology Annual Meeting
March 14	Modified Virus Vaccine Shows Promise in Mouse Model of Breast Cancer
March 17	Akesis Pharmaceuticals Provides Preliminary Data from Phase IIa Trial of AKP-020 for Type 2 Diabetes
March 17	Sepracor Presents Safety Data on Omnaris AQ and Omnaris HFA Nasal Sprays at American Academy of Allergy Asthma and Immunology (AAAAI)
March 17	Baxter Presents Latest Clinical Trial Results of Gammagard Liquid Administered Subcutaneously
March 17	Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
March 17	Medivation's Dimebon Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress
March 17	Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
March 17	Valeant Pharmaceuticals Reports Encouraging Phase IIb Results at Treatment Week 12 for Taribavirin
March 17	New Data Show Advair Reduces Asthma-Related Hospitalization and Emergency Department Visits
March 17	Fludarabine, Mitoxantrone and Zevalin Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkin's Lymphoma
March 17	New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
March 17	Hepatitis C Virus DNA Vaccine Shows Safety When Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study at Karolinska University Hospital
March 17	GSK Data Suggests Efficacy of Advair and Serevent is Not Impacted by Genetic Profile
March 17	Greer's Sublingual-Oral Immunotherapy Clinical Trials Supporting the Safety of Home-Administered Treatment Published in the Annals of Allergy, Asthma and Immunology
March 17	New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
March 17	Study Shows Privigen 10% Liquid Immunoglobulin Preparation for Intravenous Use, Is an Effective Replacement Therapy in Patients with Primary Immune Deficiencies
March 17	NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
March 17	Study Analyzed Long-Term Symbicort Use in Children With Persistent Asthma
March 17	Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn Technology in Diabetic Foot Ulcers
March 17	Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to Reolysin During a Phase I Clinical Trial
March 17	Scientists Identify New Leads for Treating Parasitic Worm Disease
March 17	MediGene Achieves Excellent Efficacy Data of EndoTAG-1 in Clinical Phase II Trial in Pancreatic Carcinoma
March 17	Nuvelo Announces Phase 2 Sonoma-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
March 18	Hollis-Eden Pharmaceuticals Reports Positive Preliminary Data from Ongoing Phase I/II Clinical Trial with Triolex in Obese Insulin Resistant Subjects
March 18	Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
March 18	VioQuest Pharmaceuticals Announces Presentations at Annual Meeting of the American Association for Cancer Research
March 18	NPS Reports Successful Gattex Extension Study
March 18	Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
March 18	iCo Therapeutics iCo-009 (Oral Amphotericin B) Published in Leading Drug Delivery Journal
March 18	CeraShield Coated Endotracheal Tubes Provide up to 21 Days of Protection against Bacterial Colonization in Preclinical Testing
March 18	NovaBay Pharmaceuticals (NBY) Publishes on the Design of New Class of Antimicrobial Compounds It Named Aganocides
March 18	BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept
March 18	Study Compares Bronchodilatory Effects of Symbicort and Advair in Adults With Asthma
March 18	C1-Esterase Inhibitor Concentrate Rapidly Relieves Abdominal and Facial Attacks in Patients with Hereditary Angioedema, According to Pivotal Study
March 18	Lipid Sciences' HDL Mimetic Peptide Demonstrates Significant Anti-Atherosclerosis Effect in a Key Animal Model
March 18	Data Presented at International Psoriasis Meeting Support Potential New Role for Biologic Treatment Etanercept in Management of Childhood Psoriasis
March 18	Leading Rheumatologists Agree Clinical Remission a Key Goal in Rheumatoid Arthritis
March 18	960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter
March 18	Lev Presents Results of Phase III Study Supporting Safety and Efficacy of Cinryze (C1 inhibitor) as Prophylactic Therapy for HAE
March 18	Orexo's Product NLA Nasal Spray Shows Excellent Local Tolerability in Patients with Rhinitis
March 18	Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
March 19	Medivir: Lipsovir Prevents Cold Sores - Phase III Clinical Trial Results First to Show Prevention by Early Treatment
March 19	Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
March 19	Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
March 19	X-ray Images from Liver Phase I Trial Presented at Society for Interventional Radiology 33rd Annual Scientific Meeting
March 20	EPIX Pharmaceuticals Announces Discontinuation of PRX-00023 Clinical Development Program
March 20	Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels
March 20	Adherex to Present ADH-1 Phase I/II Melanoma Trial Data at the 2008 Annual Meeting of the American Society Of Clinical Oncology (ASCO)
March 20	ZIOPHARM Presents Promising Early Data from Phase Ib Study of Indibulin at 6th International Symposium on Targeted Anticancer Therapies
March 20	RXi Pharmaceuticals to Present Data on the Cellular Mechanism of RNAi Interference at Keystone Symposia's RNAi, MicroRNA, and Non-Coding RNA Meeting
March 20	NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis
March 21	Antigenics to Present Phase 3 Oncophage (vitespen) Data in Kidney Cancer at European Association of Urology Annual Congress
March 21	Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
March 21	International Actemra Rheumatoid Arthritis Study Highlighted in The Lancet
March 21	Perioperative Eloxatin-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
March 21	Novel drug Actemra significantly improves the debilitating symptoms of Rheumatoid Arthritis in patients who have an inadequate response to standard therapy
March 24	MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
March 24	Spectrum Pharmaceuticals Presents Data on SPI-1620, a Novel Adjunct to Cancer Therapy, at the 6th International Symposium on Targeted Anticancer Therapies
March 24	Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
March 24	Baraclude (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
March 24	Accentia Biopharmaceuticals to Announce Top-Line SinuNase Phase 3 Clinical Trial Results Later Today
March 24	AVAX to Present Results of Phase I-II Study of MVax at 2008 Meeting of the American Society of Clinical Oncology (ASCO)
March 24	Revised: Challenging the Norm May Lead to New Therapy for Type 2 Diabetes
March 25	Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
March 25	Oxford Biomedica Report Encouraging New Phase II Trial Results with Trovax in Prostate Cancer
March 25	Chelsea Therapeutics Reports Significant Efficacy of CH-4051 in Reduction of Collagen-Induced Arthritis in Animal Model
March 25	Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
March 25	EPIX Pharmaceuticals to Present Phase 2a Alzheimer's Data at Keystone Symposia
March 25	Researchers Report Neublastin Virtually Restores Complete Long-term Sensory Motor Function in Preclinical Studies
March 25	Circulation Publishes Data Showing Kynapid (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
March 25	ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans
March 25	Nastech Pharmaceutical Company Inc. to Present RNAi Data
March 25	Yale and Asuragen Scientists Show That a microRNA Can Reduce Lung Cancer Growth
March 25	Strong Trend of Effectiveness Indicated in Lipid Sciences' First in Man Clinical Trial of HDL Selective Delipidation
March 26	Cancer Researchers at Manhattan-based St. Vincent's Comprehensive Cancer Center Discover Genes That Can Determine How Patients Respond to Pre-Leukemia Drug
March 26	Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
March 26	Cerus Announces Major Presence at Upcoming International Society of Blood Transfusion Conference
March 26	Levitra Therapy Suitable for Men With High Cholesterol
March 26	Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACC's 57th Annual Scientific Session
March 26	Cerus Announces Major Presence at Upcoming International Society of Blood Transfusion Conference
March 26	Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
March 26	CytRx to Present Stroke Recovery Data at the Sixth International Workshop on The Molecular Biology of Stress Responses
March 26	Best Practice Database: Complimentary Excerpt of Scientific Publications Strategy Study
March 26	Nature Publishes Study by Santaris Pharma Scientists and Collaborators: LNA-mediated microRNA Silencing in Non-human Primates
March 27	ImmuneRegen BioSciences Releases Study Results Showing Homspera Stimulates Adult Stem Cell Activity
March 27	Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
March 27	Vertex Announces Positive Results for VX-770, an Oral Investigational Agent That Targets a Defective Protein Responsible for Cystic Fibrosis
March 27	Vertex Announces Positive Results for VX-770, an Oral Investigational Agent That Targets a Defective Protein Responsible for Cys
March 27	SGX Pharmaceuticals Provides Update on SGX523 Clinical Trials
March 27	Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
March 27	Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease
March 27	Orexo Announces Results Confirming the Clinical Profile of OX17 In Reflux Disease (GERD)
March 27	Kaiser Permanente Study Shows That a Larger Abdomen in Midlife Increases Risk of Dementia
March 27	New data presented at European Association of Urology (EAU) Congress in Milan
March 27	Genfit Shows Encouraging Results in GFT505 First Clinical Trial of Efficacy
March 27	IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
March 27	RxGen and Santaris Pharma Use LNA-antimiR Technology to antagonize the liver-expressed microRNA-122 in Non-Human Primates and to Safely Lower Serum Cholesterol
March 28	Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity during the Performance of Cognitive Tasks
March 28	Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
March 28	Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
March 28	LDL Particle Measurement by NMR Recognized in Consensus Statement by the American Diabetes Association and the American College of Cardiology
March 28	Sirtris Pharmaceuticals Scientific Advisor Shows SIRT1 Activation Improves Huntington's Disease In Preclinical Model
March 28	Positive Results from Visudyne Combination Therapy Study Reported at Annual Macula Society Conference
March 28	VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia
March 31	UCB (BE) - Phase II results for CDP791 in non-small cell lung cancer support further clinical development
March 31	Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
March 31	Crestor Outcomes Study Jupiter Closes Early Due To Unequivocal Evidence Of Benefit
March 31	Update on Achieve: A Study of Merck's Investigational Extended-Release Niacin/Laropiprant (Cordaptive)
March 31	12-Month Data From Endeavor IV Show Strong Clinical Efficacy of Medtronic's Drug-Eluting Stent Across All Patient Groups
March 31	Merck/Schering-Plough Pharmaceuticals Comments on Results of the Enhance Study
March 31	ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests
March 31	Vertex Pharmaceuticals Announces Acceptance of Late-Breaker Abstract on Telaprevir
March 31	Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
March 31	BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
March 31	Phase III Data Showed Taranabant, Merck's Investigational Medicine to Treat Obesity, Led to Statistically Significant Weight Loss
March 31	Abbott's XIENCE V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
March 31	Alnylam Presents Pre-clinical Data from Hypercholesterolemia, Liver Cancer, Ebola, and Progressive Multifocal Leukoencephalopathy (PML) Programs at RNAi Keystone Symposium
March 31	Drug-Eluting Stents Outperform Bare Stents in Heart Attack
March 31	Gamma Secretase Modulators Show Promise in Alzheimer's Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
March 31	Endeavor Stent Safety Profile Affirmed in Long-Term Experience
March 31	Delcath Systems Presents Positive Phase II Data on Delcath PHP System in Treatment of Inoperable Liver Metastases
March 31	Large Study Gives Nod to Drug-Eluting Stents in Heart Attack
March 31	MIV Preliminary Nine-Month Human Data Affirms Excellent Safety and Efficacy of VESTAsync Polymer-Free Drug-Eluting Stent
March 31	Novelos Therapeutics Announces Continued Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Harvard Cancer Center
March 31	Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
March 31	Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
March 31	Seven Abstracts Featuring Exelixis Compounds Accepted for Presentation at 2008 ASCO Annual Meeting
March 31	SPIRIT II Explores Long-Term Performance of XIENCE V Stent
March 31	Abbott's Phase III Studies of Investigational TriLipix (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
March 31	Argos Therapeutics Presents Positive Phase 1 Safety Data for its Arcelis Platform in HIV at Keystone Symposia
March 31	Landmark OnTarget Trial Demonstrates Micardis is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
March 31	King Pharmaceuticals Presents Positive Results of CorVue Phase III Clinical Trials at the American College of Cardiology (ACC) Annual Scientific Conference
March 31	Patients Treated with Merck's Investigational Extended-Release Niacin/Laropiprant (Cordaptive) Reported Significantly Less Flushing Than Patients Treated with Niaspan in Phase III Study
March 31	New Data Showed Actos (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
March 31	Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
March 31	Repros Reports Interim Safety Results From Ongoing One-Year Open Label Study of Proellex(R) in the Treatment of Uterine Fibroids

Clinical Trial Results Archive

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec

More News Resources

Pharma News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals

	A to Z Drug List	Drugs by Condition	Pill Identifier	Drug Interactions Checker	Medical Encyclopedia	Medical Dictionary	Pharmaceutical News & Articles	Community Forums
Welcome Guest\|Register or Sign In My Viewing History \| My Drug List \| My Interactions Lists \| Member Offers